Neuralink 開始 CAN-PRIME 研究，這是其完全植入式 BCI 的首次國際試驗

這家馬斯克支持的 BCI 製造商現在可以開始 CAN-PRIME 研究，這是其首次國際試驗。它以美國正在進行的 PRIME 研究為基礎，評估該公司的完全植入式無線 BCI

Elon Musk-backed brain-computer interface (BCI) company Neuralink has announced the launch of its first international clinical trial, named CAN-PRIME. The study will evaluate the safety and efficacy of the company's fully implantable, wireless BCI device in Canadian residents with limited or no ability to use both hands.

馬斯克 (Elon Musk) 支援的腦機介面 (BCI) 公司 Neuralink 宣布啟動首個國際臨床試驗，名為 CAN-PRIME。該研究將評估該公司完全植入式無線 BCI 設備對雙手使用能力有限或無能力的加拿大居民的安全性和有效性。

The CAN-PRIME study builds upon the ongoing PRIME study in the U.S., which is investigating the use of Neuralink's BCI in people with quadriplegia. The study will assess the initial functionality of the BCI, called Telepathy, in enabling participants to control external devices with their thoughts.

CAN-PRIME 研究建立在美國正在進行的 PRIME 研究的基礎上，該研究正在調查 Neuralink 的 BCI 在四肢癱瘓患者中的使用情況。該研究將評估腦機介面（BCI）的初始功能（稱為心靈感應），使參與者能夠用他們的思想控制外部設備。

The study is open to Canadian residents who have sustained a cervical spinal cord injury or have been diagnosed with amyotrophic lateral sclerosis (ALS), rendering them with limited or no ability to use both hands.

這項研究開放給患有頸脊髓損傷或被診斷患有肌萎縮側索硬化症（ALS）、導致雙手使用能力有限或無法使用的加拿大居民。

"This study marks an important step towards developing innovative BCI technology that has the potential to transform the lives of individuals with neurological disorders around the world," Neuralink said in a statement.

Neuralink 在聲明中表示：“這項研究標誌著開發創新腦機介面技術的重要一步，該技術有可能改變世界各地神經系統疾病患者的生活。”

Neuralink, founded by Musk in 2016, is among several companies and research institutions worldwide striving to advance BCI technology.

Neuralink 由馬斯克於 2016 年創立，是全球多家致力於推動 BCI 技術的公司和研究機構之一。

The company's implant, unveiled during a livestreamed event in January, is designed to be wirelessly charged and boasts electrode-laced threads that can be inserted deeper into the brain. Neuralink also boasts a specialized R1 robot, crafted to implant the BCI system while navigating around vasculature.

該公司的植入物在一月份的直播活動中推出，設計為無線充電，並擁有可以插入大腦更深處的電極線。 Neuralink 還擁有一款專門的 R1 機器人，專門用於在血管系統周圍導航時植入 BCI 系統。

According to analysts, the total addressable market (TAM) for BCI technology in the U.S. alone is valued at approximately $400 billion. The technology holds immense promise in enhancing the quality of life for individuals with neurological disorders, ranging from paralysis to blindness and deafness.

據分析師稱，僅在美國 BCI 技術的總潛在市場 (TAM) 價值就約為 4000 億美元。該技術在提高患有神經系統疾病（從癱瘓到失明和耳聾）的患者的生活品質方面具有巨大的前景。

Earlier this year, Neuralink showcased the first human implant of its BCI device, with a nine-minute livestream demonstration revealing Noland Arbaugh using the implant to move a computer cursor and play chess online. The company also announced plans for another human implant this past summer.

今年早些時候，Neuralink 展示了其腦機介面設備的首個人體植入物，透過九分鐘的直播演示，諾蘭·阿博 (Noland Arbaugh) 使用該植入物移動計算機遊標並在線下棋。該公司也在去年夏天宣布了另一個人體植入物的計畫。